Adult Cardiac Literature Watch - Second Quarter 2006

Complications of diagnostic cardiac catheterisation: results from a confidential inquiry into cardiac catheter complications.
West R, Ellis G, Brooks N.
Heart 2006;92:810-14.

Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae?
Kapetanakis EI, Medlam DA, Petro KR, et al.
Circulation 2006;113:1667-74.

Management of unsuccessful thrombolysis in acute massive pulmonary embolism.
Meneveau N, Séronde M, Blonde M, et al.
Chest 2006;129:1043-50.

Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery.
Niemi TT, Suojaranta-Ylinen RT,  Kukkonen, Sinikka I, Kuitunen AH.
Anesth Analg 2006;102:998-1006.

Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes. 
Bajraktari G, Koltai MS, Ademaj F, Kuitunen, AH.
Int J Cardiol 2006;110:206-11

Pulmonary artery growth fails to match the increase in body surface area after the Fontan operation.
Tatum GH, Sigfússon G, Ettedgui JA, et al.
Heart 2006;92:511-14.

Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans.
Cheung MMH, Kharbanda RK, Konstantinov IE, et al.
J Am Coll Cardiol 2006;47:2277-82.

Risk and determinants of myocardial injury during off-pump coronary artery bypass grafting.
Nathoe HM, Moons KGM, van Dijk D, et al.
Am J Cardiol 2006;97:1482–86.

Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience.
Chieffo A, Morici N, Maisano F, et al.
Circulation 2006;113:2542-47.

Complex thoracoabdominal aortic aneurysms: Endovascular exclusion with visceral revascularization.
Black SA, Wolfe JHN, Clark M, Hamady M, Chenshire NJ, Jenkins MP..
J Vasc Surg 2006;43:1081-89.

Thoracic aortic endografting is the treatment of choice for elderly patients with thoracic aortic disease.
Kern JA, Matsumoto AH, Tribble CG, et al.
Ann Surg 2006;243:815-23.

Cardiac resynchronization therapy delays heart transplantation in patients with end-stage heart failure and mechanical dyssynchrony.
Vanderheyden M, Wellens F, Bartunek J, et al.
J Heart Lung Transplant 2006;25:447-53.

Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival.
Gonzalez-Stawinski GV, Cook DJ, Chang ASY, et al.
J Heart Lung Transplant 2006;25:613-8.

HeartQuest ventricular assist device magnetically levitated centrifugal blood pump.
Bearnson GB, Jacobs GB, Kirk J, Khanwilkar PS, Nelson KE, Long JW.
Artificial Organs 2006;30:339-46.

Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.
Kim J, Montagnani M, Koh KK, Quon MJ.
Circulation 2006;113:1888-1904.

Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) and Taxus-stent evaluated at Rotterdam cardiology hospital (T-SEARCH).
Valgimigli M, Malagutti P, Rodriguez-Granillo GA, et al.
J Am Coll Cardiol 2006;47:1530-37.

Two-year outcomes after Sirolimus-eluting stent implantation: results from the Sirolimus-eluting stent in de novo native coronary lesions (SIRIUS) trial. 
Weisz G, Leon MB, Holmes, DR Jr, et al.
J Am Coll Cardiol  2006;47:1350-55.

Effects of a statewide physician-led quality-improvement program on the quality of cardiac care.
Goss JR, Maynard C, Aldea GS, et al.
Am Heart J 2006;151:1033-42.

Comparison of 19 pre-operative risk stratification models in open-heart surgery.
Nilsson J, Algotsson L, Höglund P, Lührs C, and Brandt J.
Eur Heart J 2006;27:867-74.

Octogenarians undergoing cardiac surgery outlive their peers: a case for early referral.
Stoica SC, Cafferty F,  Kitcat J, et al.
Heart 2006;92:503-06.

Drug eluting stents: an updated meta-analysis of randomised controlled trials.
Roiron C, Sanchez P, Bouzamondo A, Lechat P, Montalescot G.
Heart 2006;92:641-49.

Cognitive outcomes in elderly high-risk patients after off-pump versus conventional coronary artery bypass grafting: a randomized trial.
Jensen BO, Hughes P, Rasmussen LP, Pedersen PU, Steinbrüchel DA.
Circulation 2006;113:2790-95.

Long-term results of tacrolimus monotherapy in cardiac transplant recipients.
Lubitz SA, Baran DA, Alwarshetty MM, et al.
J Heart Lung Transplant 2006;25:699-706.

Wound healing complications with de novo sirolimus versus mycophenolate mofetil-basedregimen in cardiac transplant recipients.
Kuppahallya S,Al-Khaldib A, Weisshaar D, et al.
Amer J Transplant 2006;6:986–92.

Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report.
Kobashigawa JA, Miller LW, Russell S, et al.
Amer J  Transplant 2006;6:1377–86.

Pioglitazone prevents acute and chronic cardiac allograft rejection.
Kosuge H, Haraguchi G, Koga N, Maejima Y, Suzuki J, Isobe M.
Circulation 2006;113:2613-22.

Stent versus open surgery for acute and chronic traumatic injury of the thoracic aorta: a single-center experience.
Andrassy J,  Weidenhagen R, Meimarakis G, Lauterjung L, Jauch KW, Kopp R.
J Trauma 2006;60:765-72.

Mitral repair best practice: proposed standards.
Bridgewater B,  Hooper T,  Munsch C et al.
Heart 2006;92:939-44.

Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both?
Newby DE, Cowell SJ, Boon NA.
Heart 2006;92:729-734

Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications.
Messika-Zeitoun D, Johnson BD, Nkomo V, et al.
J Am Coll Cardiol 2006;47:2521-27.

Left ventricular remodeling impacts the function of the Quattro stentless mitral valve bioprosthesis (a 4-year experience).
Doss M, Aybek T, Wood JP, Martens S, Wimmer-Grienecker G, Moritz A.
Am Heart J 2006;151:943.e1- 943.e4.

Frequency of atrial fibrillation in patients having mitral valve repair or replacement for pure mitral regurgitation secondary to mitral valve prolapse.
Berbarie RF,  Roberts WC.
Am J Cardiol 2006;97:1034–44.

Outcome of watchful waiting in asymptomatic severe mitral regurgitation.
Rosenhek R, Rader F, Klaar U, et al.
Circulation 2006;113:2238-44.

Protected carotid stenting in high-risk patients with severe carotid artery stenosis. 
Safian RD, Bresnahan JF, Jaff MR, et al.
J Am Coll Cardiol 2006;47:2384-89.